Literature DB >> 11747706

Expanding global distribution of rotavirus serotype G9: detection in Libya, Kenya, and Cuba.

N A Cunliffe1, W Dove, J E Bunn, M Ben Ramadam, J W Nyangao, R L Riveron, L E Cuevas, C A Hart.   

Abstract

Serotype G9 may be the fifth most common human rotavirus serotype, after serotypes G1 to G4. In three cross-sectional studies of childhood diarrhea, we have detected serotype G9 rotaviruses for the first time in Libya, Kenya, and Cuba. Serotype G9 constituted 27% of all rotaviruses identified, emphasizing the reemergence of serotype G9 and suggesting that future human rotavirus vaccines will need to protect against disease caused by this serotype.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11747706      PMCID： PMC2631875          DOI： 10.3201/eid0705.017521

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


  17 in total

1.  Epidemiological study of the G serotype distribution of group A rotaviruses in Kenya from 1991 to 1994.

Authors:  S Nakata; Z Gatheru; S Ukae; N Adachi; N Kobayashi; S Honma; J Muli; P Ogaja; J Nyangao; E Kiplagat; P M Tukei; S Chiba
Journal:  J Med Virol       Date:  1999-07       Impact factor: 2.327

2.  Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules.

Authors:  M A Miller; L McCann
Journal:  Health Econ       Date:  2000-01       Impact factor: 3.046

3.  Molecular characterization of serotype G9 rotavirus strains from a global collection.

Authors:  M Ramachandran; C D Kirkwood; L Unicomb; N A Cunliffe; R L Ward; M K Bhan; H F Clark; R I Glass; J R Gentsch
Journal:  Virology       Date:  2000-12-20       Impact factor: 3.616

4.  Apparent re-emergence of serotype G9 in 1995 among rotaviruses recovered from Japanese children hospitalized with acute gastroenteritis.

Authors:  T Oka; T Nakagomi; O Nakagomi
Journal:  Microbiol Immunol       Date:  2000       Impact factor: 1.955

5.  Emerging group-A rotavirus and a nosocomial outbreak of diarrhoea.

Authors:  M A Widdowson; G J van Doornum; W H van der Poel; A S de Boer; U Mahdi; M Koopmans
Journal:  Lancet       Date:  2000-09-30       Impact factor: 79.321

6.  Molecular characterization of rotavirus in Ireland: detection of novel strains circulating in the population.

Authors:  F O'Halloran; M Lynch; B Cryan; H O'Shea; S Fanning
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

7.  Rotavirus strain diversity in Blantyre, Malawi, from 1997 to 1999.

Authors:  N A Cunliffe; J S Gondwe; S M Graham; B D Thindwa; W Dove; R L Broadhead; M E Molyneux; C A Hart
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

Review 8.  Epidemiology of rotavirus infection in Thailand.

Authors:  N Maneekarn; H Ushijima
Journal:  Pediatr Int       Date:  2000-08       Impact factor: 1.524

9.  Characterisation of rotavirus G9 strains isolated in the UK between 1995 and 1998.

Authors:  M Iturriza-Gómara; D Cubitt; D Steele; J Green; D Brown; G Kang; U Desselberger; J Gray
Journal:  J Med Virol       Date:  2000-08       Impact factor: 2.327

Review 10.  Rotavirus serotypes: classification and importance in epidemiology, immunity, and vaccine development.

Authors:  Y Hoshino; A Z Kapikian
Journal:  J Health Popul Nutr       Date:  2000-06       Impact factor: 2.000
View more
  24 in total

1.  Serologic and genomic characterization of a G12 human rotavirus in Thailand.

Authors:  M Wakuda; S Nagashima; N Kobayashi; Y Pongsuwanna; K Taniguchi
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

2.  Eight-year survey of human rotavirus strains demonstrates circulation of unusual G and P types in Hungary.

Authors:  Krisztián Bányai; Jon R Gentsch; Roger I Glass; Mária Uj; Ilona Mihály; György Szücs
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

3.  Characterization of serotype G9 rotavirus strains isolated in the United States and India from 1993 to 2001.

Authors:  A R Laird; J R Gentsch; T Nakagomi; O Nakagomi; R I Glass
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

4.  High incidence of G9P181 rotavirus infections in Italian children during the winter season 1999-2000.

Authors:  S Arista; E Vizzi; M C Migliore; E Di Rosa; A Cascio
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

5.  Genetic and antigenic characterization of rotavirus serotype G9 strains isolated in Australia between 1997 and 2001.

Authors:  Carl Kirkwood; Nada Bogdanovic-Sakran; Enzo Palombo; Paul Masendycz; Helen Bugg; Graeme Barnes; Ruth Bishop
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

6.  Detection of the emerging rotavirus G9 serotype at high frequency in Italy.

Authors:  Vito Martella; Valentina Terio; Giuseppe Del Gaudio; Mattia Gentile; Paola Fiorente; Salvatore Barbuti; Canio Buonavoglia
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

Review 7.  Rotavirus diversity and evolution in the post-vaccine world.

Authors:  John T Patton
Journal:  Discov Med       Date:  2012-01       Impact factor: 2.970

8.  Assessment of the epidemic potential of a new strain of rotavirus associated with the novel G9 serotype which caused an outbreak in the United States for the first time in the 1995-1996 season.

Authors:  H Fred Clark; Diane A Lawley; Alyssa Schaffer; Janice M Patacsil; Amy E Marcello; Roger I Glass; Vivek Jain; Jon Gentsch
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

9.  Human astrovirus gastroenteritis in children, Madagascar, 2004-2005.

Authors:  Dimitrios C Papaventsis; Winifred Dove; Nigel A Cunliffe; Osamu Nakagomi; Patrice Combe; Pierre Grosjean; C Anthony Hart
Journal:  Emerg Infect Dis       Date:  2008-05       Impact factor: 6.883

10.  Norovirus infection in children with acute gastroenteritis, Madagascar, 2004-2005.

Authors:  Dimitrios C Papaventsis; Winifred Dove; Nigel A Cunliffe; Osamu Nakagomi; Patrice Combe; Pierre Grosjean; C Anthony Hart
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.